David Y Liu

PTGX

David Y Liu serves as Chief Scientific Officer at Protagonist Therapeutics, Inc. (PTGX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$702.9K

Net Position

Net Seller

$702.9K

Companies Traded

PTGX

Active Period

Aug 2021

1 total trades

Most Recent

Sell PTGX

Aug 19, 2021 · $702.9K

David Y Liu's Insider Trading at Protagonist Therapeutics, Inc. (PTGX)

Buys

0 · $0.00

Sells

1 · $702.9K

Total Shares Bought

Total Shares Sold

14,779

PTGX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 19, 2021	Sell	14,779	$47.56	$702.9K	58,254

Related Insiders

Asif Ali

officer: Chief Financial Officer

PTGXSell · Apr 21, 2026

MOLINA ARTURO MD

officer: Chief Medical Officer

PTGXSell · Mar 27, 2026

SELICK HAROLD E

director

PTGXSell · Mar 27, 2026

PATEL DINESH V PH D

President and CEO

PTGXSell · Mar 25, 2026

Lewis T Williams

Director

PTGXSell · Feb 17, 2026

William D. Waddill

Director

PTGXSell · Feb 6, 2026

Explore More Insider Trading Data

PTGX Insider Trading Activity

View all insider trades at Protagonist Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity